Overview

An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms

Status:
WITHDRAWN
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the safety and efficacy of Amisulpride as an add-on therapy or alternative monotherapy in treating patients with schizophrenia or schizoaffective disorder who have treatment-resistant positive symptoms and who are not eligible for treatment with clozapine due to intolerance, failure from a prior clozapine trial, or unwillingness to be treated with clozapine.
Phase:
NA
Details
Lead Sponsor:
University of California, Los Angeles
Collaborator:
PoloMar Health LLC
Treatments:
Amisulpride